Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ildiko Csiki

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Did targeted therapy fail cyclooxygenase too?Ildiko Csiki, David H Johnson
The Journal of General Psychology|August 3, 2002
Case-mixing effects on anagram solutionKenneth L Witte, Joel S Freund, Ildiko Csiki
Therapeutic Advances in Medical Oncology|September 4, 2012
Sonic hedgehog pathway expression in non-small cell lung cancerMalvi Savani, Yan Guo, David P Carbone, et al.
Molecular Cancer Therapeutics|June 11, 2009
Regulated cell death pathways: new twists in modulation of BCL2 family functionNidhish Sasi, Misun Hwang, Jerry Jaboin, et al.
Clinical Nuclear Medicine|March 23, 2010
Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancerDaniel E Spratt, Roberto Diaz, James McElmurray, et al.
Cancer Research|January 7, 2006
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancerIldiko Csiki, Kiyoshi Yanagisawa, Nobuhiro Haruki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Analytical Biochemistry|October 21, 2004
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancerLaine J Murphey, Myles K Williams, Stephanie C Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancerRobert Mutter, Bo Lu, David P Carbone, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Did targeted therapy fail cyclooxygenase too?Ildiko Csiki, David H Johnson
The Journal of General Psychology|August 3, 2002
Case-mixing effects on anagram solutionKenneth L Witte, Joel S Freund, Ildiko Csiki
Therapeutic Advances in Medical Oncology|September 4, 2012
Sonic hedgehog pathway expression in non-small cell lung cancerMalvi Savani, Yan Guo, David P Carbone, et al.
Molecular Cancer Therapeutics|June 11, 2009
Regulated cell death pathways: new twists in modulation of BCL2 family functionNidhish Sasi, Misun Hwang, Jerry Jaboin, et al.
Clinical Nuclear Medicine|March 23, 2010
Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancerDaniel E Spratt, Roberto Diaz, James McElmurray, et al.
Cancer Research|January 7, 2006
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancerIldiko Csiki, Kiyoshi Yanagisawa, Nobuhiro Haruki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Analytical Biochemistry|October 21, 2004
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancerLaine J Murphey, Myles K Williams, Stephanie C Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancerRobert Mutter, Bo Lu, David P Carbone, et al.
Pageof 2